Health
De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2 – Science Magazine
Many efforts to develop therapies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are focused on the interaction between the spike protein,…
Abstract
We developed a de novo protein design strategy to swiftly engineer decoys for neutralizing pathogens that exploit extracellular host proteins to infect the cell. Our pipeline allowed the design, validation, and optimization of de novo human angiotensin-converting enzyme 2 (hACE2) decoys to neutralize severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The best monovalent decoy, CTC-445.2, bound with low nanomolar affinity and high specificity to the receptor-binding domain (RBD)…
-
Noosa News19 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
Noosa News17 hours agoDeath of German shepherd Arnie prompts Brisbane community action to protect pets caught up in crime
-
General12 hours agoPerth man charged after investigation into organised crime and tobacco store attacks
-
General17 hours agoCrowe toasts talkback titan for platforming ‘voiceless’